TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT02904876

Evaluation of Early Changes Visible to the Diffusion MRI in Response to Two Years of Treatment With Tysabri in Patients With Multiple Sclerosis

Cause of deathNo reason given Automatic label, confidence 0.9, unverified. How labels are made.

The sponsor gave no reason.

Life of this trial

20142015201620172018201920202021Registered2014-12-08Started2015-03Primary completion2019-12Stopped2020-05

Vital statistics

Status
Terminated
Phase
Phase 4
Sponsor
University Hospital, Strasbourg, France
Sponsor type
University, hospital or other
Conditions
Multiple Sclerosis
Interventions
Diffusion Magnetic Resonance Imaging at 6 months
Participants
70
Sites
1
Countries
France

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.